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Abstract 
Background: Anabolic androgenic steroid (AAS) consumption, in order to enhance athletic 
performance and muscle size, started in the 50s and not longer after negative side effects on athletes 
health were reported (Lombardo 1990). Nowadays, AAS intake is increasing among non athletes and 
adolescent who seek mostly an improvement of their cosmetic appearance (Clark and Henderson 
2003), despite the quite large amount of possible drawbacks connected to AAS intake (Kicman 2008). 
Aim: The aim of this project is to understand what brings common people to utilize AAS even though 
serious side effects may happen. A possible answer to this question can be formulated by studying the 
pharmacology of AAS and the theory regarding risk and hazard perception among lay-people with 
emphasis on the relation between risk/hazard taking and reward. 
Results: It is possible to indentify two “extreme profiles” of AAS users. The first with high knowledge 
of the hazards and a right perception of the risks concerning AAS intake, so that the reward is so big 
that he is willing to accept the risks. The second with low or absent risk and hazard perception 
concerning AAS intake, so that even a moderate reward is enough to induce AAS consumption. 
Possible aspects leading to AAS intake in first subject may be societal pressure (seek of a body with 
big muscles and no fat), shortcut which AAS use may give (enhancement of muscle size and fat 
burning in a relative short period), “addiction” to beauty and psychological effects of AAS (happiness, 
libido). In the second profile psychological effects of AAS may play the major role: increase of self-
esteem, happiness, perceived strength and health may cause people not to seek information about risk 
and hazard and not to believe external warning about risks and possible hazards concerning AAS 
intake. Also, popularity of AAS, wrong examples from status symbols and disinformation may play an 
important role. Moreover, mainly for adolescents, AAS intake may be influenced by over self 
confidence and by peer pressure and „idols‟ image. 
Conclusion: The most likely reasons bringing laypeople to consume AAS are identified considering 
risk, hazard and reward perception of AAS users. We believe that the profile of the “average AAS 
user” may differ from different countries, social class, educational background, gender and age. 
However, all AAS users‟ profile should be found between the two “extreme profiles” we have 
suggested. 
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0.0 Glossary 
 
Definitions of terms being used throughout the report are given as follow (Quoted from 
Christensen et al. 2003): 
 
Risk source: “Activity, condition, energy or agent potentially causing unwanted 
consequences/effects”: in our case the risk source can be identified as anabolic androgenic 
steroid use. 
Hazard: “The inherent property/properties of a risk source potentially causing 
consequences/effects”: for a list of hazard connected to AAS intake see table 1 chapter 4.3. 
Consequence/effect: “Result of a realized hazard that may be caused by exposure to an agent 
or energy”: In our case consequences/effects caused by AAS intake are the outcomes given by 
the hazards listed in table 1 chapter 4.3. 
Severity: “Expression of the weight allocated to a consequence/effect based on type and 
degree”: in our case severity can be thought as different in two negative consequences of AAS 
intake such as pain at the injection point or cardiovascular diseases. 
Risk: “Probability of a given consequence/effect of a given severity and extent under given 
specified circumstances” 
Concerning AAS intake, risk is considered as the probability that a hazard may happen. 
 
Hazard perception (used as a synonym for hazard knowledge): a person who has knowledge 
of all the hazards related to AAS intake (thus all the possible consequences/effects) is 
believed to have a high hazard perception. 
Risk perception: a person who has knowledge of the frequency of consequence/effect caused 
by AAS intake and who knows and understands all the probability that a negative effect may 
happen to oneself, is able to evaluate properly the risk and therefore is believed to have a right 
risk perception.  
Risk acceptance (use as synonym for risk tolerance): throughout the report risk acceptance is 
considered as the willingness of people to accept risks and hazards connected to AAS intake. 
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0.1 List of abbreviation 
 
17βHSD: 17β hydroxysteroid dehydrogenase 
3βHSD: 3β hydroxysteroid dehydrogenase 
AAS: anabolic androgenic steroid 
ACTH: Adrenocorticotropic hormone: alternative name for corticotropin. 
AR: androgen receptor 
ARA: androgen receptor associated protein 
cAMP: Cyclic adenosine monophosphate 
CBP/p300: Coactivator proteins that are usually found to be working together 
CNS: central nervous system 
DHEA: Dehydroepiandrosterone, 3β-hydroxy-5-androsten-17-one 
DHT: 5-α-dihydrotestosterone 
DS: sulphated ester of DHEA 
EPO: Erythropoietin 
ER: estrogen receptor 
GABA: γ-Aminobutyric acid 
GnRH: Gonadotropin-releasing hormone  
GRIP1: glucocorticoid receptor interacting protein 1 
HDL: High-density lipoprotein 
Hsp90: heat shock protein 90 
IGF-1: Insulin growth factor type 1 
LDL: Low-density lipoprotein 
p160: cell surface protein p160 
p300: E1A binding protein p300 
PKC: Protein kinase C 
SARM: selective androgen receptor modulator 
SERM: selective estrogen receptor modulator 
 
The most meaningful terms of the list are defined in the appendix (Chapter 10.0). 
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1.0 Introduction: 
 
The consumption of doping substances by athletes of both genders is an old phenomenon, like 
“magic elixirs” which provide an increase in muscles mass, strength and power. In particular, 
anabolic androgenic steroids (AAS) started to be used in the 50s and had a rapid widespread 
in sport men circles (Lombardo 1990, Kicman 2008). These substances are chemically 
manufactured from the parent compound testosterone (Clark and Henderson 2003) and are 
involved in bone and skeletal muscles growth and fat tissue reduction, increase in strength, 
power, endurance and faster recovery from exercises, resulting in better performances in a 
great number of sports (Lombardo 1990). As years passed by, side effects of these compounds 
started to be observed, demonstrating both body and psychiatric health disorders. Increased 
aggression, tendency to suicide, risk to cardiovascular and reproductive system, liver and 
brain health among others, are connected with the intake of AAS (Kicman 2008). The health 
risks for people participating in these activities may also be related to the illegality of the 
substances which may be new drugs and never been tested. Furthermore, the amount taken 
and sterility may not be supervised by doctors or experts leading to an increased risk in the 
use of these compounds (Parkinson et al. 2006). Information about these drugs may be 
obtained through unreliable sources such as websites selling bodybuilding supplements that 
do not have scientific relevance and control and may give misleading instructions. They may 
induce to increasing side effects by suggesting combination of different drugs in order to sell 
as much as they can, showing therefore an obvious conflict of interests. Besides agonistic 
purposes, anabolic androgenic steroids are taken for cosmetic purposes since they combine 
muscles enhancement with fat burning (Lombardo 1990). The most extraordinary example of 
AAS consumption is in the practice of bodybuilding. The muscular volume is elevated to an 
extreme level without apparent fat on the body in order to enhance the cosmetic of the 
bodybuilders, making them often look “unnatural”. Such extreme examples are usually linked 
to the intake of also others substances such as growth hormone and many others more or less 
known. Although body-culture has a history as old as ancient Greeks times, the extreme 
attention on body appearance leading to bodybuilding-culture is a fairly young phenomenon 
which has become more and more popular especially in the past 25 years (Chapman D.). 
Bodybuilders may decide whether or not to participate in professional competitions that are 
similar to a fashion show since the only purpose is to be judged on their “beauty”. However, 
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both professional and laypersons bodybuilders have their body in the center of their mind 
(body-culture) in a way that everything they do aims at the development and embellishment 
of their body (Barland 2005). At the center of their lives is the training schedule which is 
always a must and only around it the social life is established. Therefore, the building of the 
body for bodybuilders is not just a hobby but is the center and a way of living. This process 
develops gradually from an initial stage where the individual focuses only in the training; to 
the second stage where also diet is taken into serious consideration until an eventual third 
stage where doping can be the tool to refine what training and diet have done (Barland 2005). 
There is a lot of ongoing talking among bodybuilders on how training, diet and doping should 
be performed. However, the general idea that one can perceive reading bodybuilding papers is 
that everything has to be extreme. Training has to be always as hard as possible and has to 
push the own weight-lifting limit to heavier loads each time. Each day the bodybuilder should 
focus only on particular muscles in order to center all physical and psychological energy on 
the training on that specific area. The probably most common training schedule among 
bodybuilders counts one day of rest every four days of training so that the person can regain 
the energy he has lost (Barland 2005). Diet is also very strict, the general idea is to maximize 
protein intake and to minimize carbohydrates and fat consumption in order to give the body 
the ingredients to build up muscles as well as eliminate as much fat as possible. To a certain 
extent such attention about training and diet might be healthy or at least not too problematic. 
However, serious concerns arise when the person enters the “third stage” of bodybuilding, the 
one involving the use of doping (Barland 2005). It is known that doping usage has deleterious 
effects on one‟s health which may be related to the amount administrated, the kind of doping, 
the composition of the eventual “doping cocktail” and the sterility and hygienic conditions of 
the compounds. It seems strange at first glance that a person who is so concerned about his 
own body appearance and diet ends up consuming illegal substances that are very likely to 
affect his own health. However, doping usage and the intake of anabolic androgenic steroids 
in particular, has become widespread even among laypersons and adolescents (Clark and 
Henderson 2003).  
Therefore, our challenge in this report will be to analyze risk and hazard, perception and risk 
acceptance of laypersons bodybuilders that consume AAS. 
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2.0 Problem formulation: 
 
In light of what is mentioned in the introduction, concerns about health risks arise. There is 
lack of studies in literature relating AAS usage with risk and hazard perception and 
acceptance even though much has been investigated in each field. Because of the wide 
spreading of AAS usage even among laypersons and adolescents in the last 25 years it is 
important to investigate this phenomenon in order to give material to future risk management 
studies that will need to find ways to counteract this problematic situation. The report will 
provide background about AAS pharmacology and knowledge concerning related health risks. 
Afterward, we will review the literature defining the concepts of hazard, risk perception and 
reward. At the end we will try to understand why people use these substances by relating the 
body of literature concerning AAS health hazards with risk perception, acceptance and 
reward. 
 
In summary, our report aims to answer the following question: 
 
1) What brings common people to utilize AAS even though serious side effects may happen? 
 
 
3.0 Semester theme requirement: 
 
During the third semester work, students have to gain experience by working with natural 
science related to cultural and societal contexts. We believe our project fits the third semester 
theme requirement since we will discuss issues relating people and science in a societal 
scenario such as AAS use among laypeople. By carrying out this work, we have to study both 
AAS pharmacology and the science behind risk assessment. Moreover, since AAS are 
increasingly used by laypeople to which science is brought indirectly and sometimes by 
misleading websites or unprofessional people, we will be concerned about the possible effects 
on people influenced by a “wrong” science. 
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4.0 Theory 
4.1 Doping substances 
 
This report focuses on the risk, hazard and reward perception concerning the intake of AAS 
by layperson bodybuilders; however, often these drugs are mixed with other doping 
substances in order to amplify their effects and/or try to counteract their side effects. 
Therefore, even if they are not a major concern of this work, we will start mentioning briefly 
also other drugs besides AAS that bodybuilders and athletes in general may consume aiming 
the increase in performance or the improvement of the athletes‟ motivation (Rivier et al.). 
The most common doping substances are: 
 ACTH which is supposed to stimulates the production of corticosteroid and related 
anabolic effects. Side effect may include hypertension, hyperglycemia, osteoporosis, 
weakness of the immune system etc. 
 Amphetamines are taken to reduce fatigue, increase aggression and self esteem and the 
users feel in general more strong and ready for a competition. Many drawbacks come along 
with the use of amphetamines such as: paranoia, hallucinations, hypertension, psychosis, 
addiction, insomnia etc. 
 Beta blockers are taken mainly in those sportive practices where the athletes seek calm 
and precision, like archery, target practice and clay pigeon shooting etc. Side effects may 
include cardiac rhythm problems, cardiac insufficiency, insomnia, hypoglycemia etc. 
 Caffeine (high doses) stimulates the muscles and the central nervous system and the 
effects remind cocaine and amphetamines. Side effects may include hypercholesterolemia, 
tachycardia, anxiety, insomnia, headaches etc. 
 Cocaine is a stimulant of the central nervous system whose effects are similar to 
amphetamines and caffeine. Side effects include strong addiction and cardiovascular, 
cerebrovascular and neurological complications etc. 
 Chorionic gonadotropin increase testosterone production and counteract some effects 
of AAS intake such as testicular atrophy. However, the consumption of chorionic 
gonadotropin may lead to thrombosis, psychic disorders etc. 
 Morphine derivatives are usually used to alleviate pain consequent to trauma, cramps 
and violent sports. Negative effects include addiction, convulsions, mood alteration, nausea 
etc. 
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 Diuretics stimulate the excretion of water and salts from the body and are used in 
order to trick doping tests of illicit substances by diluting doping drugs in the urine. They also 
may be consumed to decrease body weight and therefore permit the athletes to enter lower 
weight categories in weight categories sports. Side effects include dehydration, muscular 
cramps and change in potassium levels. 
 EPO (Erythropoietin) is a hormone which stimulates red blood cells production and 
thus increases the oxygenation of muscle tissue and physical recovery after physical activity. 
The increase of blood viscosity due to the gain of red blood cells may cause severe problems 
such as vascular thrombosis possibly leading to heart attack or stroke. 
 Growth hormone stimulates the growth of men and women and also regulates the 
metabolism of sugars proteins and fats. It is taken by athletes and in particular bodybuilders 
for the possible anabolic effects. Side effects include hypertrophy of the viscera, hirsuitism, 
diabetes mellitus, cardiovascular diseases etc. 
 Insulin is taken because is believed to increase the level of growth hormone, have 
anabolic effect and anticatabolic activity. Side effects include anxiety, cardiovascular 
complications, hypoglycemia, damage to the brain etc. 
 Insulin growth factor type 1 (IGF-1) is a hormone similar to insulin and the 
endogenous production is stimulated by the growth hormone. The intake of IGF-1 seems to 
decrease body fat mass and have anabolic effects. Side effects due to IGF-1 intake include 
problems to the hearth, diabetes, impotence among others. (Rivier et al., Grattini 2005). 
 
4.2 Androgens background 
 
Androgens are hormones that perform many tasks in the human body such as muscle and 
bone build up, regulation of reproductive system, liver, kidney, central nervous system, etc. 
Generally speaking, androgens are directly involved with the masculinization process such as 
the anabolic development of muscles and bones. However, these hormones perform different 
actions during the life of an individual; in an animal fetus androgens are related with the 
growth of the ejaculatory duct and the genital organs on the external of the body (Kicman 
2008). In puberty they are associated with the further development of muscles, bones, 
testicles, prostate, seminal vesicles, larynx, and hair in many parts of the body, sexual desire 
and aggression. Around 95% of the testosterone is created in the Leydig cells in the testicles 
but a small amount comes also from the ovaries in females and the adrenal gland in males and 
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females. Ovaries and adrenal gland can make other kinds of androgens but they usually have a 
less strong action as compared to testosterone (Kicman 2008). 
In target organs, androgens may be inter-converted to one another by special enzymes leading 
to a modulation in their effects (figure 1): 
 In the reproductive system, testosterone is reduced to the more “powerful” DHT (5-α-
dihydrotestosterone) that has higher affinity to the AR (androgen receptor). 
 In adipose tissue and some portions of the brain, testosterone is converted to estradiol 
by the enzyme aromatase which binds to estrogen receptor. 
 In both skeletal muscles and bones the anabolic event is believed to be mainly 
triggered by the direct binding between testosterone to the androgen receptor and by the 
conversion of testosterone to estradiol but more studies are needed to clarify this mechanism 
(Kicman 2008). 
 
 Figure 1 Interconversion of testosterone in other 
steroids in target tissue. In reproductive tissue 
testosterone is reduced to DHT by 5-α-reductase 
which enables it to have a stronger affinity to the 
androgen receptor. In the adipose tissue and some 
portion of the brain it is converted to estradiol by 
aromatase that will have affinity for the estrogen 
receptor rather than the androgen receptor. In 
skeletal muscles and bone it will probably either 
bind directly to the androgen receptor or be 
converted by aromatase to estradiol. Modified from 
(Kicman 2008). 
 
 
 
It is important to mention that in target tissues are also present some co-regulator proteins 
which affect the androgen receptor‟s transcription and therefore regulate the magnitude of the 
androgen effect and the target DNA sequence (Kicman 2008). 
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4.2.1 Activity of testosterone and mechanism of action: 
 
Testosterone is usually administrated orally or intramuscularly. Athletes who use anabolic 
androgenic steroids as doping aim to intake a compound which has a high ratio anabolic 
effect/androgenic activity. In this way they can enhance the desirable effect of increase in 
muscular mass, strength and power and decrease the negative effects on other tissue that a 
supraphysiological level of AAS may lead to (Kicman 2008). In order to design AAS with a 
high anabolic/androgenic effect, much research on the molecular structure of the parent 
compound testosterone has been done. Usually, testosterone is first structurally modified to 
increase its anabolic proprieties and reduce the androgenic activities by the removal of the 
CH3 in the A ring, introduction of a CH3 group in the carbon 1 of the A ring or to the carbon 
7 of the B ring, formation of a double bond between carbon 1 and 2 of the A ring, attachment 
of different groups at the carbon 2 of the A ring, bind of a pyrazole ring to the A ring and bind 
of a Cl or OH to the carbon 4 of the A ring (Figure 2). Testosterone can be administrated 
orally by the binding of CH3 or CH2CH3 group to the carbon 17 in the D ring. This will 
sterically counteract the oxidation of the hydroxyl group during the presystemic metabolism 
in the liver increasing the bioavailability. For intramuscular administration, esterification of 
the OH group attached to the carbon 17 of the D ring will confer the molecule a less rapid 
absorption and therefore it will prolong the effect of the molecule (Kicman 2008). 
 
 
Figure 2 Testosterone molecule. The numbers refer to the structural modifications mentioned in the text above 
that confer stronger anabolic proprieties and weaker androgenic activities to the molecule and oral or 
intramuscular activity. Modified from Kicman 2008. 
 
Steroids with the highest anabolic activity compared to the androgenic features are preferred 
by athletes. There has been some controversy about the experiments performed to determine 
the ratio myotrophyc (anabolic) activity/androgenic activity, several studies however, have 
been made on rats comparing the increase in mass of the levator ani muscle (myotrophyc 
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activity) and ventral prostate (androgenic activity) when were fed with different steroids 
(Kicman 2008). Steroids are reduced by the enzyme 5-α-reductase in reproductive tissue but 
not in muscle tissue. As mentioned above, testosterone has a high effect on reproductive tissue 
because the reduced 5-α-dihydrotestosterone (DHT) in the reproductive system as a strong 
affinity to the androgenic receptor. Thus, the ideal steroid for athletes is one that has a strong 
affinity to the androgenic receptor in its “normal” form but a weak affinity for the androgenic 
receptor in its reduced form. In this way it would have a high myotrophyc (anabolic) activity 
and a low androgenic activity. Examples of drugs with a high ratio myotrophyc 
activity/androgenic activity are esterified nandrolone (the most popular), oxymetholone, 
methandienone and stanozolol. Indeed, even these drugs have a certain androgenic activity 
which can lead for example to excessive hair growth and masculinization of women and 
children as well as other side effects which will be discussed later through the report (Kicman 
2008). 
 
4.2.2 AR receptor: 
 
The androgen receptor is a transcriptional factor that belongs to the nuclear receptor 
superfamily (Mangelsdorf 1995, Kicman 2008, Negro-vilar 1999, Gelman 2002, Gelman 
2002) and has been identified in two isoforms in fibroblasts of genital skin: A and B, with 
isoform A being 1:10 of the total amount of AR receptor (Wilson et al. 1994). Isoform A does 
not feature in an intact N terminal as isoforms B, that is, N terminal in isoform A is shorter. 
Tasks of isoform A are not yet fully understood and it is not clear whether tasks are different if 
present in other tissues. Moreover it remains to be elucidated how the ratio between the two 
isoforms may change among different tissues (Wilson et al. 1994). The androgen receptor 
may be found both in the cytosol or in the nucleus and the exact location may differ in 
different tissue (Kicman 2008). Testosterone and others androgen steroids are quite 
hydrophobic compounds that are easily able to cross the phospholipidic bilayer of the plasma 
membrane, diffuse into the cytoplasm and bind the AR inside the cell (Campbell 2008). The 
androgen receptor features a ligand binding domain, a central DNA binding domain and at 
least two transcriptional activation domains. Receptor homodimerization is a very important 
process for the activity of the androgen receptor. In fact, it may be essential for 
steroid/receptor complex translocation to the nucleus, for binding with cofactors and the DNA 
target sequence etc (Centenera et al. 2008, Kicman 2008). Androgen receptor 
homodimerization can be different for distinct kind of cells and may take place through 
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different interaction between the androgen receptor monomers. For example, 
homodimerization can occur via binding of two DNA binding domain subunits. This occurs 
upon DNA binding and seems to be crucial for gene targeting and transcription. Otherwise, 
the N-terminal of one receptor complex may bind with the C-terminal of another receptor 
complex leading to an N-C terminal dependent homodimerization. Interaction between the N 
terminal and C terminal of the same monomer may also take place. Another way in which 
homodimerization can occur is through binding of two ligand binding domain of the two 
monomers. However, homodimerization often occur via the combination of these different 
interactions between androgen receptor monomers (Centenera et al. 2008, Kicman 2008). 
Without steroid bound, the receptor is in the inactivated form in complex with Hsp90, p23 and 
others proteins. Hsp90 is a heath shock protein which seems to be particularly important 
because it enhances the affinity between the steroid and the receptor and increases the 
solubility of the receptor in the cytoplasm. On the other hand Hsp90 may impair nuclear 
recognition, DNA sequence recognition, dimerization, and interplay between AR and 
coactivators. However, once the steroid binds this complex, it will allosterically activate this 
receptor stabilizing the active form which has high affinity to the DNA target region. 
Moreover, it will create a conformational change in the receptor which will unbind it from the 
other complex proteins (Hsp90, p23 etc.) and will move towards the nucleus. Reached the 
nucleus, the DNA binding domain will bind to a specific DNA sequence triggering activation 
and transcription of the gene (Kicman 2008). These processes are regulated from various 
cofactors such as CBP/p300, GRIP1, ARAs, p160 and Tip60 which can modulate the activity 
of the AR such as increase/decrease the transcriptional activity and the expression of certain 
DNA sequence rather than others. For example the coactivator p160 is very important because 
it activates histone acetyltransferase that remodels the conformation of chromatin enhancing 
the affinity between DNA binding domain and the DNA sequences. Others may change the 
structure of the AR leading to many different transcription activities (Gelman 2002). 
Cofactors are thus extremely important to modulate the activity of the AR, and since in 
different tissues are found dissimilar cofactors that may be present in different concentration 
is easily understandable how the same AR receptor can trigger dissimilar biological activity in 
different tissues in our body (Negro-vilar 1999). Unlike estrogens or thyroid hormone 
receptors that bind coactivators in the ligand binding domain, AR binds coactivators on the N 
terminal domain. AR activity has also been suggested to be regulated by phosphorilation 
which seems to be very important for both the transcription and transduction pathways which 
may involve cAMP and PKC (Gelman 2002). 
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4.2.2.1 Selective androgen receptor modulators (SARMs) 
 
Recently the interest of scientists has been attracted by the selective androgen receptor 
modulators (SARMs). The idea behind SARMs is the development of androgenic steroids 
which have sensitivity only for a particular tissue. Since the androgen receptor is expressed in 
a multitude of different tissues, from genitalia to muscles, skin, brain, liver etc., the sensitivity 
of the androgen steroids in androgen therapy to only the target tissue would prevent negative 
side effects due to the stimulation of other tissue. If for example an elderly man has 
osteoporosis problems, a SARM which has an anabolic effect on skeletal muscles and bones, 
and no effect on sexual organs, liver, kidney etc would probably help the subject. On the 
contrary, if the target tissue is the prostate, we would need a SARM which has hypothetically 
no effect on muscles, bones, liver etc (Negro-vilar 1999, Kicman 2008). This may be achieved 
in the future years, if scientists can point out all different kinds of cofactors (coactivators or 
corepressors) which play an important role in the activity of the steroid-androgen receptor 
complex. The development of SARMs which can induce conformational changes in the 
receptor that in turn affect its affinity to the different cofactors in different tissue may provide 
tissue selectivity (Negro-vilar 1999). The potential therapeutic use of SARM is very wide 
such as therapy for osteoporosis, anemia, male contraception, muscular dystrophies etc. in 
men and osteoporosis, ovarian failure, autoimmune diseases, libido enhancer etc. in women 
(Negro-vilar 1999, Kicman 2008). In these fields the optimization of SARM for therapy in 
women is not as understood as it is in men. But while the development of selective estrogen 
receptor modulators SERMs has reached good results, more work and research will be needed 
to therapeutically use SARMs as well as SERMs (Negro-vilar 1999). 
 
4.3 Anabolic effect of AAS and health side effects 
 
Anabolic steroids have been taken for years by male and female athletes in order to increase 
their performances. A classic example are the extraordinary amount of medals won by athletes 
of the ex East Germany. In particular female competitions in which strength was an essential 
feature were abnormally won by East Germany female contestants. After Germany was 
reunified and old documents were brought to light, a massive and systematic doping program 
has been discovered for athletes including intake of anabolic steroids (Kicman 2008). 
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A study (Bhasin et al. 2001) has selected 61 men who have been divided in 5 groups with the 
administration of 25, 50, 125, 300, or 600 mg every week of testosterone enanthate during a 
period of twenty weeks. To these subjects were also administered GnRH which is a hormone 
that hinder the physiological testosterone production. This study indicated that the intake of 
testosterone was correlated to an increase in muscles size, strength (highest force which can 
be performed), power (force in a time interval), hemoglobin, IGF-I and to the reduction of the 
body fat and HDL cholesterol. These effects were also tightly connected to the amount of 
testosterone administered. Whereas prostate-specific antigen, sexual activity, libido, liver 
enzymes level and spatial cognition did not seem to be particularly influenced by the 
testosterone concentration for this 20 week period. Moreover, androgens might increase 
endurance of athletes by increasing the maximum amount of oxygen carried by red blood 
cells via interacting with the bone marrow (Lombardo 1990). AAS may also enhance protein 
synthesis, increase the level of collagen synthesis and bone mineral density. These effects are 
believed to be due to the enhancement of protein synthesis by testosterone, in fact, AAS have 
been suggested to up-regulate transcription since they seem to enhance RNA polymerase 
(Lombardo 1990, Parkinson et al. 2006). Glococordicoids are steroid hormones involved in 
catabolic activities, leading to muscles atrophy via the catabolism of proteins. AAS have also 
been suggested to impair protein degradation via interfering with glococordicoids receptors 
(Lombardo 1990). Moreover, AAS may enhance the production of growth hormone and 
insulin-like growth factor1 (IGF-1) (Parkinson et al. 2006). 
A study (Parkinson et al. 2006) made an internet survey on 500 users of AAS (98.8% of 
which men) in order to point out the drug habits of AAS consumers. From this research many 
interesting results were shown. The majority of people (78.4%) taking AAS supplements were 
non competitive athletes or bodybuilders that consumed AAS for improving only their 
appearance. Almost two thirds of AAS consumers were less than 30 years old and the 26% of 
the users began when they were less than 20. One out of ten consumed AAS for at least 10 
years, more than 40% for more than 4 years and 45% of the 500 participants take AAS for at 
least 6 months per year. Concerning the amount of AAS, there may be an increasing trend 
during the past 10 years of drugs intake, in fact if in 1997 another study indicated that most 
AAS user consumed maximum 500mg of AAS per week, this research in 2006 reported that 
the most AAS consumer used at least 1000mg per week. Moreover, almost all users admitted 
to use more than one AAS simultaneously and in injectable formulations. 95% of the AAS 
users take various drugs for muscle enhancement and other medications to counteract the side 
effects. The 25% combine AAS with growth hormone and insulin as compared to a survey 
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made in 1997 in which just 12% of the subjects consumed growth hormone and 2% insulin. 
Furthermore 48 out of 500 used injectable IGF-1. Interestingly, 496 out of 500 users reported 
some kind of side effect and 70% revealed more than 2 symptoms such as sexual dysfunction, 
insomnia, testicular atrophy, pain at the injection site, mood alteration etc. It is also worth 
noticing that most of the AAS consumers prefer the intake of other drugs to alleviate the side 
effects of AAS instead of reducing or stop AAS intake. Furthermore, almost all participants 
admitted the intake of AAS through intramuscular injection, around 50% of them revealed 
pain at the site of injection and more than 10% of them practice dangerous injections because 
of equipment sterilization and conditions. Only one out of ten of the AAS users find AAS 
legally via a physician, the nine out of ten remaining obtain AAS in an illegal way for which 
the content, sterility and quality are not guaranteed. Internet provides 70% of this illegal 
marked and Mexico seems to be the major exporter providing 37.4% of this market. Even 
though AAS clearly induced negative side effects among these subjects, the intake was related 
to hazardous practices and the sources of the drugs were not reliable, only 61.4% of the users 
declared to be aware of possible negative health problems (Parkinson et al. 2006). 
In order to minimize the possible adverse effects, anabolic steroids are generally taken for 
about 6/12 weeks and afterward is expected a stop of some months (Kicman 2008). However, 
bodybuilders may not have periods of stop but they may intake them incessantly and at high 
dosage. In a recent review (Kicman 2008) possible negative effects deriving from the 
uncontrolled intake of anabolic steroids are summarized and are here presented in table 1. 
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Table 1 Possible negative effects deriving from the uncontrolled intake of anabolic steroids (Kicman 2008). 
 
 
 
As we can see from the table above, the negative effects may count for many different kind of 
tissue (neuronal, muscular, liver, skin etc.). This is probably because the androgen receptor is 
located in many different kind of tissue. Therefore, bodybuilders have to face also these 
possible health problems besides their masculinization and cosmetic enhancement. 
 
4.3.1 Effect on behavior: 
 
Physiological concentration of androgenic steroids are related to positive feelings such as 
happiness, relax and libido. In particular testosterone may also play an important role in 
cognition-related functions. But the intake of androgenic steroids for both men and women 
may have several consequences on behavior patterns (Kicman 2008, Svare 1990).  
Studies on rats fed with androgenic steroids reviewed by Clark and Henderson 2003, have 
shown an increase of aggression that is probably due to a decrease of serotonin tone, 
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alteration of arginine vasopressin (hormone found in the posterior pituitary), alteration of 
substance P (a peptide involved in pain perception) and GABA (main inhibitory 
neurotransmitter in mammalian CNS).  Androgenic steroids may also alter reward by 
interfering with the expression of dopamine receptors and dopamine levels. In fact, there is 
possibility that androgenic steroids may increase the effect of other drugs (such as 
amphetamine) in reward behaviors. This possibility goes along with the fact that people 
taking androgen steroids have been shown to be more likely to consume other drugs. Another 
important parameter for reward as well reproductive behaviors is the level of opioid and 
opioid receptors expression. Opioid also regulate the synthesis of arginine vasopressin and 
other hormones which are involved in aggression and in the feeling of fear. However, more 
studies are needed to clarify these mechanisms and whether androgenic steroids can change 
the concentration of opioid in zones critical for the reward. AAS may also increase the 
synthesis of stress hormones but future studies will need to clarify the exact mechanisms 
(Clark and Henderson 2003). High doses of androgenic steroids in both sexes have been 
suggested to perturb the sexual life and in males they can lead to a lower production of 
physiological testosterone and sperm (Clark and Henderson 2003). Concerning libido, studies 
on rats show different results. In fact, depending on the AAS administered, high doses of AAS 
may increase, have no effect or hinder sexual behaviors of male and female rats. Also, high 
doses of different AAS seemed to interact with the estrous cycle by shortening it or 
completely stop it (Clark and Henderson 2003). Anxiety is enhanced by AAS probably 
because of a regulatory effect of anabolic androgenic steroids on the GABAa receptor which 
is related to the expression of anxiolytic inducing factors. This effect may be the result of the 
direct regulation of GABAa receptor subunits synthesis, a direct allosterical modulation and a 
result of the stimulation of the synthesis of other GABAa receptor allosteric regulators (Clark 
and Henderson 2003). 
Depression may also occur when the intake of androgenic steroids is stopped. For example if 
the athlete blocks the consumption of androgenic steroids right before a competition in order 
to trick doping tests, he may run into depression crisis and lack of motivation during the 
competition. Athletes who want to cheat in this way however, may choose low transdermal 
rather than intramuscular administration of testosterone before the doping test so that the 
testosterone level would drop faster and it would be possible to trick the inspection (Kicman 
2008). 
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4.4 Prohormone Supplements 
 
Dehydroepiandrosterone (DHEA), androstenedione and androstenediol are identified as 
molecules which are steroid precursor of testosterone and are promoted as prohormone 
nutritional supplements (andro supplements) and sold for testosterone enhancement and 
muscle size growth. These supplements however cannot be commercialized without 
prescription since January 2005 and are classified as anabolic steroids by The Anabolic 
Steroid Control Act of 2004 (Brown et al. 2006). Several websites, for example 
http://www.bodybuilding.com/store/hp/d200.html, are still selling DHEA, therefore, we 
believe that a brief review on the pharmacology and the possible side effects of intake of 
DHEA and androstenedione might be interesting since it is related to AAS and the 
manipulation of information given to laypeople by unscientific sources. 
Dehydroepiandrosterone (3β-hydroxy-5-androsten-17-one; DHEA) is created by the adrenal 
cortex from 17-hydroxypregnenolone and it can be transformed in vivo to several hormones 
such as testosterone, androstenedione, androstenediol and estradiol. In males DHEA is 
normally synthesized 15md/day and it has a normal 7-31 nmol/L concentration in the serum. 
Intake of 50mg DHEA by men (23 years old in average) was able to rise androstenedione 
serum concentration in 1 hour by 150% but serum testosterone concentration and serum 
estrogens concentrations were not modified, furthermore, to 19 men (23 years old in average) 
were administrated orally 150mg/day (to 9 men) or placebo (to 10 men) DHEA during a 
period of 8 weeks in a “body resistant-training program”. Results showed that serum 
concentration of androstenedione rose after 2 and 5 weeks while total and free testosterone 
concentrations in the serum did not change after DHEA intake and training, moreover 
enhancement in strength was detected to be similar in men after intake of DHEA or placebo 
(Brown et al. 1999, Brown et al. 2006). In another study, DHEA was administrated to 14 old 
males (58.8 years old in average), results demonstrated that both 50mg  and 100mg intake of 
DHEA raised serum concentration of DS (sulphated ester of DHEA), while testosterone and 
dihydrotestosterone concentrations in the serum were not altered (Arlt et al. 1999). In women, 
on the other end, intake of DHEA has been reported to increases serum testosterone, 100mg 
of DHEA intake (n=2 women), was able to raise testosterone concentration in the plasma to 3-
4 times the normal concentration within 90 minutes after intake (Mahesh et al. 1962).In 
another study (Mortola et al. 1990), a study was carried out on 6 postmenopausal women 
between 46 and 61 years of age where DHEA intake was 400mg orally for four times a day 
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(1600mg/day, n = 3 women) or placebo (n = 3 women) in a 28 days period. Results showed 
that after the first dose of DHEA all androgen concentrations increased in the serum, 6 fold 
increase in DHEA serum within 3 hours after intake, 12 fold increase in androstenedione 
serum concentration within 4 hours after intake, 2.5 fold increase in testosterone serum 
concentration within 4 hours after intake, 4 fold increase within 2 hours and 15 fold increase 
within 3 hours in DHT (dihydrotestosterone) serum concentration. During the DHEA intake 
period, the highest concentration of androgens in the serum was detected after 2 weeks: 12 
fold increase for DHEA, 9 fold increase for testosterone, 20 fold increase for DS, 
androstenedione and DHT. Furthermore, decrease of HDL cholesterol was detected after 1 
week and it remained 20-30% lower than the normal level for all 28 days period; body fat 
remained also constant either after DHEA intake or placebo (Mortola et al. 1990).  
Androstenedione (androst-4-ene-3, 17-one) and androstenediol (4-androstene-3β, 17βdiol) are 
produced from 17-hydroxyprogesterone or from DHEA. In males about 1.4md/day of 
androstenedione is normally synthesized and a 3-10 nmol/L concentration is normally present 
in the serum. The adrenal gland is responsible of secreting androstenedione and 
androstenediol which are in turn transformed to testosterone by 17β hydroxysteroid 
dehydrogenase (17βHSD) or by 3β hydroxysteroid dehydrogenase (3βHSD) respectively, to 
estrogens with the action of aromatase or to DHT by the activity of 5α reductase. These 
transformations occur in several parts of the body such as skeletal muscles, adipose tissue, 
skin and prostate gland. A study (King et al. 1999) has demonstrated that doses of 100 mg of 
androstenedione are not responsible for increasing testosterone serum concentration in men 
(n=10, 19 - 29 years old) within 6 hours after ingestion and androstenedione intake for a 
period of 8 weeks does not raise testosterone serum concentrations and do not lead  to 
enhancement of skeletal muscle adaptation during resistance training (n=10 300g/day 
androstenedione and n=10 placebo; 19 - 29 years old); these results are in accordance to other 
researches which showed that androstenedione is conversed to inactive molecules such as 
conjugated testosterone and androsterone right after ingestion, moreover, after 
androstenedione intake, decrease of HDL-C serum concentration has been reported, thus 
suggesting possible negative consequence of androstenedione intake in young men (Brown et 
al. 2006, King et al. 1999). In women, on the other hand, intake of androstenedione has been 
shown to increase testosterone plasma concentration up to 4 and 6  fold the normal 
concentration (n=2 women) within 90 minutes after androstenedione administration (Mahesh 
et al. 1962). 
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Herbal extracts have been created in order to inhibit enzymes responsible to convert 
androstenedione to inactive substances; such extracts are for example derived from saw 
palmetto, indole-3-carbinol, chrysin and Tribulus terrestris. A study has shown however, that 
these substances were not able to rise concentration of free and total testosterone in the serum 
after 6h from the ingestion of androstenedione (Brown et al. 2006). 
From all these results, both DHEA and androstenedione intake in men are only responsible to 
increase serum levels of weak hormone precursors such as DHEA and DS or to be 
transformed in inactive molecules. It is suggested that they do not promote raising of 
testosterone concentration and do not increase strength in training period carried out by men 
(contrary to website claims). In women on the other hand, DHEA and androstenedione 
consumption may cause negative effects, since testosterone concentration is increased and 
decrease in HDL cholesterol is reported (which is believed to increase risk of heart disease 
where it is present in low concentration). Enhancement of testosterone level as discussed 
previously in the report is responsible to cause side effects such as acne, facial hair and 
general hirsuitism (chapter 4.3) and increase in testosterone levels may also lead to negative 
psychological effects (chapter 4.3.1). It is therefore quite clear that there are few or none 
benefits in prohormone supplements and the consumption of these kinds of substances should 
be discouraged, enhanced even by the fact that selling of testosterone precursors has been 
banned by the U.S. Food and Drug Administration (Brown et al. 2006).  
 
4.5 Risk and hazard 
 
One general description of risk may be given using two concepts: reality and possibility. Risk 
therefore, is seen as the possibility that an unwanted reality (hazard) may happen as a 
consequence of human actions, natural events and technologies (risk sources) (Renn 1998). 
Hazards therefore are menaces to humans and what is important for them. For example, motor 
vehicles are a risk source, car crash may be seen as the hazard related to motor vehicle, 
whereas the possibility of car crashing is the risk associated to that hazard. 
Consequence/effect of car crashing may be identified as death of people involved in the 
hazard (Hohenemser et al. 1983). 
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Table 2 Annual fatality percentages of several hazard connected activities or natural events calculated 
analyzing 100.000 persons at risk (modified from Slovic 1986) 
Risk sources leading to 
hazards 
% of annual 
fatalities 
Risk sources 
leading to hazards 
% of annual 
fatalities 
Motorcycling 2 Motor vehicles 0,024 
Aerial acrobatics 
(planes) 
0,5 Police work 0,022 
Smoking (all causes) 0,3 Boating 0,005 
Sport parachuting 0,2 Rodeo performer 0,003 
Smoking (cancer) 0,12 Hunting 0,003 
Fire fighting 0,08 Fires 0,0028 
Hang gliding 0,08 Floods 0,00006 
Coal mining 0,063 Lightning 0,00005 
Farming 0,036 Meteorite 6*10
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Other psychological studies in public perception however, have divided the meaning of risk in 
relation to the context in which the term is utilized thus identifying four descriptions of risk 
(Renn 1998): 
- Risk is perceived as random, the arbitrary aspect rather than the amount of 
probabilities accounts for concerns among people. In this group are placed risks 
connected to hazards derived by artificial sources with high catastrophic consequence 
(i.e. nuclear power). 
- Risk is related to an undetectable menace to health or to welfare. Consequences are 
not immediate and they usually involve small number of people. Information about 
these kinds of risks and hazards are usually not from self experience, but they often 
come from external sources (i.e. food additives, pesticides radioactive substances). 
- Risk is a balance between gains and losses, it is mostly used in financial gains or 
losses relative to gambling, lotteries and investment among others. Judgments are 
connected more to the variances of gains and losses that to the expected value lost or 
won. 
- Risk taking is voluntary and there is control on the degree of risk. Part of this group 
are all the activities in which dangerous circumstances have to be controlled with 
personal skills. (i.e. extreme sports). 
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4.5.1 Risk Perception 
 
Studies have been made about how people evaluate risks. Laypersons, for instance, when they 
are asked to rate risks, they normally do not have accessible statistical proofs and they usually 
rely on what they have heard or observed about the posed risk (Slovic et al. 1979). 
Psychological pathways which have been found to vary risk perception are difficulties in 
understanding statistical values (innumeracy), cognitive processes (heuristics), motivational 
factors and feelings (Klein et al. 2007). 
First of all, it has been shown how difficult for people it is to interpret numerical information 
and how persons respond differently to proportion, probability and frequency information. For 
example, “50%” is often used by people who are unsure to estimates their own percentage of 
risk, showing imprecision and no connection to statistic backgrounds. Furthermore, people 
may not think about co-occurring events or risk accumulation caused by often or multiple risk 
contact: 
- it may not be clear for people that the percentages of all probable events if all the 
possibilities are taken into account, must give 100%.  
- the possibilities of not connected events must be multiplied with each other and not added to 
each other. 
- if there is a probability that event A leads to event B, there is not necessarily the same 
probability that event B leads to event A. As an example, the proportion of smokers who 
contract lung cancer is considerably lower than people affected by lung cancers who smoke. 
- people may not understand that risk can accumulate exponentially over time, for instance, 
risk of HIV contraction is even overestimated in a single relation with a HIV-seropositive 
partner while it is very misunderstood that risk strongly accumulates after multiple relations 
with HIV-seropositive partners  (Klein et al. 2007). 
Studies have revealed a number of “resource-saving” rules (heuristics) that people may use 
when judging risks, two of them are „availability‟ and „overconfidence‟ (Slovic et al. 1979). 
Availability influences risk perception, in a way that people evaluating the risk, think of it to 
be likely and recurrent if they can easily visualize or remind that risk (Slovic et al. 1979). For 
example, people are more influenced by a plane crash with multiple fatalities (also 
overexposed by media) than the same number of deaths caused by car accidents (Klein at al. 
2007). Overconfidence instead, shows that people often do not understand how little is the 
knowledge and how much information they should have about the problems and risks they are 
subjected to (Slovic et al. 1979). 
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Risk perception is also influenced by several motivational causes, when people are 
considering their mortality they are first determined to decrease their mortality risk and 
secondly they are incline to behave in manners which can raise self-esteem and social 
acceptance, for example use of suntan lotion may decrease cancer skin risk but also prevent 
skin to become tanned (which may have influences in social acceptance), thus leading to 
incongruity between decrease in mortality risk and personal meaning enhancement (Klein et 
al. 2007). 
Diversities about perceived risk have been found among different cultures and social-
economic classes (Klein et al. 2007) and between laypeople and experts, studies have shown 
that experts judgments of risk of activities or technology are strongly connected to statistical 
or calculated annual victims, whereas laypeople judgments may not be strongly related to 
annual fatalities. It is thought instead, that normal people consider other aspects into their risk 
perception, such as disaster potential, dread or severity of consequences related to a special 
risk (Slovic et al. 1979). Most people perceive low-probability high-consequence risks more 
menacing than more likely risks with fewer consequences. Furthermore other qualitative 
characteristics of risk such as personal control, voluntariness and familiarity has been 
suggested to raise risk tolerance; whereas institutional control, fear and artificial font of risk 
lead to reduction of risk tolerance or enhance awareness of risk (Renn 1998). 
Another important aspect is the difficulty to change people belief even during long time and 
with opposing evidences, people are in fact indisposed to perceive new information and to 
change their behaviors but are strongly prone to defend their believes; furthermore, poor 
information about the risk is likely to be perceived as a reinforcement of the existing ideas 
(Renn 1998; Slovic et al. 1979). 
 
4.5.2 Risk acceptance and reward 
 
Research (Starr 1969) has been carried out on the relations between risk acceptance and 
reward of eight activities, such as hunting, smoking, skiing, electric power and motor vehicles 
among others. In this study the risk was measured as a statistical probability of death per hour 
of exposure to the activity and the reward was imagined to be equivalent to the average 
contribution of the activity on a person annual income or to the money which a person spend 
on that activity. From the results obtained was possible to conclude that (Fischhoff et al. 
1978): 
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- A risk is accepted proportionally to the true and perceived reward. 
- For an equal amount of reward, people accept voluntary risks (e.g. skiing) almost 1000 
times more than involuntary risks (e.g. food preservatives) 
- The reasonable level of risk of an activity is inversely associated to the number of 
people participating in that activity. 
Another study (Fischhoff et al. 1978) has shown moreover, that perceived risk was 
unconnected to voluntariness, but the intentional nature of an activity influences its risk level 
tolerability. For example, 52 women and 24 men members of the Eugene, Oregon, League of 
Women Voters (which opinions can be considered quite similar to many private citizens), 
were asked to estimate 30 activities and technologies considering: 1) perceived reward to 
society 2) perceived risk 3) acceptability of its level of risk 4) rate of the risk on a 7 points 
scale regarding 9 aspects which could influence risk perception. 
The study comprises the 8 activities considered by (Starr 1969) and 22 more activities such as 
alcohol consumption, bicycles, contraceptives, food coloring and preservatives, nuclear 
power, pesticides, surgery, vaccinations among others. 
Reward was estimated as total possible gains, both concrete (such as money or number of job 
generated) and intangible (such as enjoyment for people or increase in health or welfare). 
Risk instead, was evaluated as total risk of mortalities per year. Aspects taken into 
consideration for evaluating possible influence on risk perception were: voluntariness, 
immediacy of consequence, familiarity of risk, control and dread, among others. 
No relationship has been found between perceived risk and reward and no substantial 
difference in risk perception has been observed when the activity was voluntary or 
involuntary. Results however, showed that reward is related to acceptability and voluntariness 
of risk, furthermore, for a set reward, a greater risk is accepted if the risk is intentional, 
immediate, well known, common and controllable (Fischhoff et al. 1978). 
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4.5.3 Risk acceptance in adolescence 
 
Risk acceptance in adolescence is linked with behaviors which are causes of major mortalities 
of teenagers. Risk acceptance may consist of voluntary actions for which there are unsure 
results and possible negative health effects. Juveniles with inadequate or no experience may 
participate in immediate reward leading actions without understanding or paying attention on 
possible direct or long-term negative outcomes. Such activities are identified in 1) Sexual 
behavior 2) Substance use 3) motor vehicle use. According to Irwin, “cognitive scope” (level 
of knowledge and understanding of an adolescent), “self-perceptions”, “perception of the 
social environment” (i.e. understanding parents, friends and teachers influence) and “personal 
values” are thought to predict risk acceptance in adolescence via the regulation effects of risk 
perception and influence of fellow groups. A survey on 640 students of a middle school and 
680 students of a high school, with age between 11-14 and 14-18 respectively, has been 
carried out in order to understand risk behavior in adolescence. Results firstly show how 
alcohol consumption, marijuana consumption, sexual intercourse and driving car over the 
speed limit, are common between both two kinds of students (Summarized in table 3) and that 
such behaviors start in early adolescence and raise in frequency in late adolescence, showing 
an inclination to decrease risk evaluation when people become older (Irwin).  
Table 3: Percentages of adolescents engaging in risk behaviors. Middle school students: n=640, ages 11-14. 
High school students: n=680, ages 14-18 (modified from Irwin) 
Health Risk Behavior Middle school High School 
Alcohol (ever used) 71.8% 84.4% 
Marijuana (ever used) 31.9% 61.4% 
Sexual intercourse 21.4% 43.9% 
Drive/ride car over speed limit 63.8% 73.4% 
 
These activities are present in all socioeconomic and racial/ethnic group and are dependent on 
gender, race and ethnic. Sexual behavior for instance, is different among black and white 
teenagers, in the study mentioned before, 29% of the students were sexually active and black 
male and females were more active than white adolescents (Irwin). 
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4.5.3.1 Anabolic steroids intake in adolescence 
 
A study (Yesalis et al. 1990) has been carried out on 3403 male students (17-18 years old) 
among 46 high schools in USA. Results showed that 6,64 % (226/3403) used anabolic 
steroids. A great number of users, felt their strength higher than the average (57.3%) and they 
believe their health to be “very good or excellent” (71.4%), showing a higher perception of 
health and strength than nonusers, furthermore AAS users who perceived their health to be 
poor were users who experienced peer pressure. A quarter of the users, specially the one who 
have experienced more than one cycle or who started to use AAS when they were younger, 
did not want to stop using AAS even after reading information about health risks connected to 
AS intake, showing characteristics connected to habituation. Moreover, heavy users (5 or 
more cycles, >6 weeks) has been shown to overestimate the number of peers using AAS, 
showing a possible way to rationalize their behavior. The results also showed that users not 
practicing sports stated in overall to use AAS in order to enhance their beauty whereas 
athletes reported to use AAS in order to increase performance. 
It is believe therefore, that AAS intake by adolescent has several common characteristics with 
other drugs use. AAS users showed refusal to stop use, inclination to ignore, not to believe or 
even fight against risks connected to drug intake and the tendency to have a high benefit 
perception prevailing the perceived risks. Several  psychological and physical results such as 
increase strength and health perception, are believe to enhance mood and self-esteem and act 
as strong motives to persist AAS intake (Yesalis et al. 1990).  
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5.0 Results: 
The aim of this project is to study the concepts of risk, hazard and reward perception in order 
to understand the reasons that bring laypeople to consume AAS in spite of possible serious 
side effects that these drugs may lead to. It has been suggested (Kicman 2008) that the intake 
of AAS is related to cardiovascular problems, reproductive system dysfunction, liver 
impairment among others (discussed in chapter 4.3). Because of these serious drawbacks, 
AAS consumption for doping purposes is banned in most countries. In spite of this, users are 
so eager to consume AAS that they may spend a lot of money and put their health at risk 
obtaining AAS even from illicit sources (Parkinson et al. 2006). For this reason, as we 
discussed in chapter 4.3 the deleterious effects of AAS may be increased due to the possible 
poor sterility and hygienic condition of the drugs. The desire of obtaining AAS even though 
the illegality and the side effects experienced by many users (Parkinson et al. 2006, discussed 
in chapter 4.3), opens a dramatic scenario and makes the analysis of this situation very 
interesting and challenging for us. In the theory part of this report we have analyzed the most 
relevant pharmacology of AAS and the concepts of risk and hazard that we have found up to 
date in the literature. Various researches on the risk and hazard perception concerning 
common hazards such as car crashes, lung cancer due to cigarettes´ smoke etc., have been 
reported since the 50s in order to improve the risk management of such hazards. To our 
knowledge, literature lacks on studies relating risk acceptance and the intake of doping 
substances in general and AAS in particular. Since the consumption of AAS is increasing in 
the population even among laypeople and adolescents, it is of primary importance to 
understand what are the reasons for making use of these substances even in light of many 
researches reporting deleterious effects of these drugs. Therefore, the challenge of this project 
is to relate the existing body of literature on risk hazard and reward perception with AAS 
consumption in order to try to fulfill this literature‟s gap. By doing this, we hope to give 
stimuli for  future research in this area, which will may consider and improve our work in 
order to give material of study to risk management concerning AAS intake. 
We first assume that AAS consumers must obtain a reward for the intake of AAS in order to 
accept the risks and hazards they perceive. Indeed, distinct consumers perceive risks, hazards 
and reward differently due to the different age, scientific background, side effects experienced 
etc. However, we can point out two “extreme profiles” of AAS users which are supposed to 
encompass all the other AAS users. 
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• The “first extreme profile” is an user who has all the right scientific background about 
AAS´ possible drawbacks (high knowledge of the hazards and right perception of the risks), 
but his reward perception is so big that he is willing to take (accept) that risk. 
• The “second extreme profile” is a subject that perceive a moderate reward from the 
intake of AAS but his risk perception concerning AAS intake and his knowledge about 
possible hazards are absent thus being only influenced by the reward. 
Now, we are going to analyze these two extreme examples distinctly and try to point out all 
the reasons for the different consciousness of the hazards, perception of risk and reward 
between these extremes. 
The “first extreme profile” subject has the right risk perception and is well informed about the 
possible deleterious effects of AAS but the reward is big enough for him to be willing to take 
the risk he perceives. In this situation the key idea for understanding his risk acceptance is to 
analyze the factors that influence his reward perception, in other words, answer the following 
question: what are the reasons inducing such a high reward perception? Laypersons do not 
consume AAS for agonistic purposes like athletes do, but rather for improving their cosmetic 
appearance. Regarding this, they may experience a certain societal pressure for appearing 
what is largely considered good looking. For this purpose AAS are the “perfect elixir” since 
they combine the increase in muscular mass with the decrease in body fat (as discussed in 
chapter 4.1.1). The societal reasons of such picture of beauty go beyond the purposes of this 
project but it is easy to guess that skinny models and athletes with big muscles are examples 
of status symbols that laypeople aim at. While male AAS consumers may mainly seek the 
anabolic activities of AAS, female may mostly look for the fat reducing effects of these drugs. 
These desirable effects may increase the self esteem of the consumer (Lombardo 1990). 
Furthermore, AAS may also be seen as a shortcut for achieving such “ideal beauty” 
(Lombardo 1990). For the same increment in muscle mass and fat reduction, an AAS user 
may perform less physical activity as compare to a non-AAS user and may achieve the same 
results in less time. For these reasons AAS are an easy way of getting results. However, for 
many AAS users, beauty is never enough, thus, some of them want to become bigger and 
bigger leading to extreme situations such as bodybuilders. For bodybuilders improvement in 
muscular mass is a process towards which they are almost addicted and they may not realize 
that beyond a certain limit such muscles enhancement is even considered ugly from the 
majority of people. Therefore, they try all methods to improve more and more their 
appearance, and the intake of AAS and usually several other drugs is a must in order to 
achieve such extreme results that represent in turn their reward. Regarding to this, there might 
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be a correlation between AAS users and anorexics people. While anorexic refuse to eat in 
order to obtain the cosmetic reward of becoming slimmer despite they are so skinny that they 
are no longer considered beautiful, so bodybuilders consume AAS in order to obtain the 
cosmetic reward of becoming bigger despite they are so big that are no longer considered 
beautiful by the majority of people. In both the anorexic person and the bodybuilder cases 
they are “blind” in front of their real appearance and they are only focused in getting slimmer 
and slimmer or bigger and bigger in order to sustain the societal pressure of beauty that they 
may feel. However, a difference between anorexics people and AAS users may be that 
anorexic people keep seeing themselves fat in the mirror even thought they are very skinny, 
while AAS consumers may realize that they are “big” but they may seek for more and more. 
Moreover, the risk concerning AAS is voluntary and since Fischhoff et al. 1978 suggested that 
for a set benefit level, a greater risk is accepted if it is intentional, intentionality may be 
another reason for the high risk acceptance of the “first extreme profile” subject. In addition 
to this, the big reward perception from the AAS intake concerning the “first extreme profile” 
may also be due to psychological effects of AAS. We have discussed in chapter 4.3.1 that 
AAS may play an important role in the happiness, libido and aggression feelings (Kicman 
2008) and therefore, besides the anabolic effects, AAS consumers may perceive a reward also 
for the psychological effects of AAS. For example AAS may be consumed by people doing 
jobs that need a certain aggression such as security guards, jail policemen, riot policemen, 
soldiers etc., for these people the increase in aggression following the consumption of AAS 
may be the reward they seek. The consumption of AAS for the solely happiness improvement 
purpose is probably unlikely since it would be more logical to make use of other drugs such 
as marijuana. However, since the stop in AAS usage may induce depression (as discussed in 
chapter 4.3.1) due to the inhibition of endogenous AAS production in people that make use of 
AAS (Kicman 2008), we may be in the situation of addiction in which the AAS user 
consumes AAS in order obtain a reward that consist in avoiding depression. 
The “second extreme profile” is a subject that perceive a moderate reward from the intake of 
AAS but his risk perception concerning AAS intake and his knowledge about the possible 
hazards are absent so he is only influenced by the reward. The key idea for understanding the 
behavior of this subject is to find out what are the possible reasons for his low risk and hazard 
perception rather than those for the big reward as it was in the “first extreme profile”. We 
have discussed above about the psychological reward consequent the intake of AAS, 
moreover, we think that the psychological effects of AAS may also alter risk perception and 
hazard perception. In fact, since AAS may make one feel good, happy and strong, the AAS 
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consumer of the “second extreme profile” may disbelieve the little information about risk and 
hazard he has, nor believe external warning about risk and possible hazard connected to AAS 
intake. This is because people are indisposed to perceive new information and to change their 
behaviors but are strongly prone to defend their believes. Moreover, poor information about 
the risk is likely to be perceived as a reinforcement of the existing ideas (Renn 1998; Slovic et 
al. 1979). In this situation, the AAS consumer may deceive himself that the risk and side 
effects connected to the AAS intake are lower or less serious due to the psychological positive 
feelings caused by AAS. In addition to this, AAS intake may lead to both immediate and non-
immediate side effects. The most common immediate side effect is pain at the site of injection 
(Parkinson et al. 2006) which is experienced by half of the AAS users (discussed in chapter 
4.3) while long term side effects include cardiovascular problems, reproductive system 
dysfunction, liver impairment etc. (Kicman 2008). Since the serious side effects are non-
immediate, laypersons may be more willing to take the risk. Doping usage is becoming a 
widespread phenomenon, similar to a fashion or a common practice among sportsmen and 
this may alter people´s risk perception. In fact, Fischhoff et al. 1978 suggested that for a set 
benefit level, a greater risk is accepted if the risk is common and therefore, people may 
become more and more willing to take the risk as the doping usage become more popular. For 
this reason, it is possible that in the future years, if risk management policies will not find a 
way to counteract doping wide spreading, AAS usage may become more and more common 
due to the increasing risk acceptance consequent to the increasing popularity of AAS 
consumption. The fact that status symbol of sport activities are being caught by anti doping 
tests may be another reason for the lower risk perception among the “second extreme profile” 
subject. In fact, “sport idols” may exert a strong influence on laypersons (mainly adolescents), 
in a way that when they get discovered positive to doping tests, laypeople may think that 
making use of AAS is a normal practice in sport since their “idols” do it. Furthermore, 
laypersons may think that the “wrong” in this case is the fact that the “idol” caught by anti 
doping tests cheated because he wanted to become stronger than the contestants by unnatural 
medium, rather than because he put himself in front of dangerous hazards due to the possible 
deleterious effects that AAS and doping in general may have on one‟s health. For this reason 
laypersons may assume AAS convincing themselves that they are not doing a wrong thing 
because they are not in a competition so they are not cheating anybody. Thus, we think that 
more attention on the health side effects connected to doping usage should be paid by mass 
media when they report news of athletes found positive to doping tests. Another reason 
concerning low risk and hazard perception in the “second extreme profile” may be that the 
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“better” body shape may induce a lower risk and hazard perception among AAS consumers. 
In fact, they may think that they are healthier because of the anabolic and reducing fat activity 
of AAS and therefore AAS users may forget about the possible drawbacks that may occur in a 
long distance period. Moreover, teenagers are usually over self secure, they often think that 
are “immortal” and therefore they may underestimate the risk and possible negative effects of 
AAS. Because of their young age, they may behave towards AAS in the same manner as 
when they start smoking. They may know the possible negative effects but since they are 
young and the serious side effects are manifested after many years of AAS or cigarettes 
consumption, they may think they would stop long before the hazards happen. However, the 
probably main reason for the low risk and hazard perception among the “second extreme 
profile” subject is the poor scientific information about the possible deleterious effects due to 
AAS consumption. This disinformation may be due to both lack of wish of the person to get 
the necessary information and from the misleading scientific information coming from other 
users or websites. By surfing on the probably most popular bodybuilding website 
(www.bodybuilding.com) is possible to get an idea of the way people and “experts” can give 
misleading and sometimes dangerous advice to each other. In that website it is all about 
increasing muscles and reducing body fat. People exchange with each other suggestion of 
different diet and dietary supplements via forums and it is clear how people follow the 
suggestions of the most well ripped ones, that is, the ones that have their profile pictures with 
most muscles and less fat. The problem is that these “idols” are neither dieticians nor doctors 
and therefore they may give out misleading information. By acquiring information from these 
sources and from these “perfectly ripped idols”, laypersons may think that they are doing the 
right thing and if they hear that consuming AAS is necessary, they may not think about the 
risk and hazard they take. There are myriads of misleading information that can be found in 
these kinds of websites in order to sell dietary supplements. For example, when talking about 
testosterone deficiency, the “expert” Spaniard00 states: “Low libido, depression and decrease 
in muscle size and strength are just a few of the symptoms of low testosterone” 
(http://www.bodybuilding.com/fun/topicoftheweek98.htm) as if the reason for example of a 
low muscular mass has to be testosterone deficiency rather than the more probable low level 
of physical activity. Ironically, little after there is a link to another web page which sells 
testosterone boosters. These websites, having many member and “experts” that give their 
opinion may alter risk and hazard perception since one may feel like trusting the “expert” 
suggestion of increasing his testosterone level for instance. By trusting the various “experts” 
and “perfectly ripped idols” the risk and hazard perception concerning AAS side effects in 
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people visiting these websites may decrease. In the same way as websites, people may obtain 
such misleading scientific information in gyms from the most “well ripped guys” in the gyms, 
television, magazines etc. 
Besides encouraging people to use AAS which may lead to deleterious side effects, these 
websites, magazines etc. may also make fool of the readers selling dietary supplements that 
may not manifest the desired effect. In fact, prohormone supplements are sold in order to 
stimulate production of hormones (i.e. testosterone) into the body. It needs just a little 
research on the web to come across websites selling prohormone supplement such as DHEA. 
One website (http://www.bodybuilding.com/store/hp/d200.html; 16/11/09 13.15) claims 
powerful and positive effects of DHEA supplement such as “helps people lose weight, burn 
fat and build muscle, and support a healthy sex drive. Dietary supplements of DHEA can help 
maintain proper levels in the body and can aid a person in their overall well being.” This 
information does not contain a solid scientific background and it is reported with a tiny note 
stating: “These statements have not been evaluated by the Food and Drug Administration. 
This product is not intended to diagnose, treat, cure, or prevent any disease.” Thus, 
suggesting a selling purpose strongly overtaking the poor and sometimes misleading or wrong 
scientific information given by non serious doctors 
(http://www.bodybuilding.com/fun/south.htm). The website states the usefulness of DHEA 
above “middle age” making no effects distinction between males and females highlighting 
instead positive effects on bodybuilders such as: “Body builders or athletes can have some of 
the greatest beneficial results. They can use it to help build strong muscles and lower body 
fat”. These statements disagree with the literature we have found concerning DHEA, as 
mentioned already in chapter 4.4. Arlt et al. 1999, found that DHEA 50mg and 100mg intake 
did not alter testosterone and dihydrotestosterone concentrations in the serum (which are 
believe to be responsible for muscles building and sex drive) in 14 old males (58.8 years old 
in average), furthermore (Brown et al. 1999) showed that after administration of DHEA 
150mg/day, in a period of 8 weeks to 19 men (23 years old in average), total and free 
testosterone concentrations in the serum did not change after DHEA intake and training. 
Moreover, enhancement of strength was detected to be similar in men after intake of DHEA or 
placebo thus showing disagreement with the website statement: “help build strong muscles”. 
Furthermore, Mortola et al. 1990 reported that body fat remained constant either after DHEA 
intake or placebo, also in disagreement with the website statement: “helps people lose 
weight”.  
The second point which we believe to be worth mentioning is the lack of clarity and 
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incongruent information concerning the dosage of the substances. On the website 
(http://www.bodybuilding.com/store/hp/d200.html) DHEA is sold in 200mg capsule/serving 
and the dosage directions state: “Take one to two servings per day with meals or meal 
replacement sports drinks”. On another page of the same website however 
(http://www.bodybuilding.com/store/dhea.html), it is stated: “Women and men over age 60 
are commonly prescribed 50mg and 100mg. Obviously since younger people produce more 
DHEA naturally, they should take less”. As we can notice, there is incongruent information 
about the suggested dosage of a drug even within the website selling it. This may give an idea 
of the lack of clarity of these sources that all they aim at is to sell as much as possible. This 
lack of clarity may induce people to waste money, or even to face negative outcomes (Mortola 
et al. 1990).  
 
6.0 Discussion 
Since literature lacks of studies on hazard, reward, risk perception and acceptance concerning 
AAS consumption we did not dispose of statistical data to figure out the reasons bringing 
laypeople to consume AAS. Therefore, we tried to consider in the results section all the most 
probable aspects inducing AAS intake in laypersons. In order to do this, we pointed out two 
“extreme profiles” of AAS users assuming that the “average AAS consumer profile” is 
somewhere in between these two extremes. In light of these results, we may suggest some 
targets to aim at in order to counteract the wide spreading of AAS usage in the population. 
For the first “extreme profile” the main targets may be: 
 To bring users down to Earth since beauty is not the only thing to seek in one´s life 
mainly if the process of reaching it involves the use of deleterious drugs. Sociological 
studies need to be performed in order to explain people that beauty is not something to 
die for and also to stress the fact that there is a connection between AAS and bad 
health besides one between AAS and beauty. The ideal picture of beauty of men in our 
society is roughly speaking “muscles and bones”, that is, big muscles and little or no 
body fat. One could argue if this should be or not one of the aims of a person´s life, 
however, this is what television and fashion shows tell us. People may achieve this 
with a balanced diet and sport that will probably enhance one´s health. However, the 
eager of getting slimmer and slimmer and building up muscles should not involve the 
use of doping substances. Societal campaigns are needed to make people understand 
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that AAS used in gyms for cosmetic purposes are not only a shortcut that help people 
becoming beautiful but are also a shortcut for bad health and negative consequences. 
Thus, these campaigns should induce the user to ask himself: is the beauty I am 
aiming at worth the serious side effects I may have to face? 
 To make the user realize that the positive physiological feelings he perceives are the 
effect of a drug on his brain and are thus “artificial”. It is not him who feels happy, 
aggressive, etc., it is something external that induce him to be like that. Since the “first 
extreme profile” subject is aware of all possible drawbacks, sociological campaigns 
are needed to induce such subject to wonder: are these “artificial” feelings worth 
depression, tendency to suicide and all the other possible side effects I may have to 
face? 
For the “second extreme profile” the main targets may be: 
 To make the subject conscious that his perception may be altered by the psychological 
effects of AAS and, therefore, he should be even more aware and think carefully 
before deciding of taking AAS. 
 To make people realize that trends in a population are not necessarily good trends. If 
the usage of AAS is becoming more and more popular it does not mean that one 
should follow it. Concerning this, campaigns are needed to induce people to think with 
their own head and wonder if they really want to make use of AAS.  
 To induce mass media stressing the wrong things in using doping when athletes status 
symbols are caught by doping tests. It should be emphasized that doping harms one´s 
health and it is not only a way of cheating in competitions. 
 To explain that even thought muscles and low body fat are generally conditions for a 
good health, if these results are achieved by the use of AAS, serious side effects may 
happen anyway. People need to understand that using AAS put their health in danger 
even though they look healthy on the outside. 
 To explain adolescents that is very likely that the intake of hormones such as AAS 
may perturb their body functions in a stronger manner than it does in adults since they 
are in a crucial period of their body development. Moreover, adolescents need to 
understand that they are not “immortal” and that their health as grownups will in part 
depend on the way they live their teen age years.  
 To inform people about the possible drawbacks connected to AAS usage. Campaigns 
are needed in order to diffuse scientific information about these drugs and the possible 
drawbacks. In particular, the right scientific knowledge about AAS should be brought 
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in the place where laypeople obtain information on AAS, that is, internet, gyms, 
magazines etc. Information about AAS besides to be easy to obtain, need also to be 
easy to understand for people that may not have any scientific background.  
 
7.0 Conclusion 
After studying the pharmacology and the possible psychological effects of AAS consumption 
it is clear that AAS intake does not only lead to „desirable‟ effects such as fat burning, bone 
and skeletal muscles growth or positive psychological feelings such as happiness, perception 
of enhanced strength or libido, but they can also cause serious negative side health outcomes 
like cardiovascular problems, reproductive system dysfunction, liver impairment and it can 
affect the psychological aspect causing depression, stress, tendency to suicide and 
aggressiveness among others (Clark and Henderson 2003, Kicman 2008).  
The possible reasons leading these subjects to consume AAS have been reported in the results 
section and are summarized in figure 3 in the next page. 
 
In summary, this project tried to identify all the possible reasons bringing laypeople to 
consume AAS considering risk, hazard and reward perception of the AAS users. We believe 
that the profile of the “average AAS user” may differ from different countries, social class, 
educational background, gender and age. However, all AAS users‟ profile should be found in 
between the two “extreme profiles” we have suggested. 
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Figure 3 The “first extreme profile”, as describe in the results section, has all knowledge about the possible 
hazards of AAS intake and it has the right perception of the risks (that is, he is aware of the magnitude of the 
probability that a hazard may happen). We believe that this subject may experience a low self esteem and a 
certain societal pressure which makes him want to appear what seems to be „good looking‟ nowadays for the 
society: big muscles and no fat on the body. This behavior, which may lead to seek more and more a perfect 
“beauty”, can be seen as a psychological aspect in some ways similar to anorexia. Second, AAS may be imagine 
as a shortcut to obtain results in less time than just training thus improving the willingness of people to use them. 
Third, AAS can lead to psychological effects which we believe to increase the reward obtained by their 
consumption: happiness, aggression (which can be seen as a positive outcomes in jobs such as security guards, 
jail policemen, riot policemen, soldiers) and enhancement of libido. Furthermore, the stopping of AAS intake 
may induce depression due to the inhibition of endogenous AAS production in people that make use of AAS 
(Kicman 2008). In this case, we can imagine to be in an addiction process, in which the user consumes AAS in 
order obtain a reward that consist in avoiding depression. The “second extreme profile” is a person who does 
not have knowledge about the possible hazards and without a right perception of the risks concerning AAS intake 
(that is, he is not aware of the hazards and therefore he is not able to perceive the right magnitude of the 
probability that a hazard may happen). First, as we described in the results section, this AAS consumer may 
disbelieve the little information about risk and hazard he has, nor believe external warning about risk and 
possible hazard connected to AAS intake. We believe this may happen because the psychological positive feelings 
caused by AAS are able to influence the risk and side effects perception connected to the AAS intake. In the 
second group we might recognize the adolescent consumers, adolescence has been shown to be characterized by 
risk taking actions such as alcohol and tobacco consumption, car driving, caused by possible over self security 
characteristic of adolescents, thus showing low risk perception and an absent or low hazard knowledge. 
Furthermore, we believe that adolescents are prone to perceive “sport idols” and status symbols as images to 
copy and aim at, thus being more influenced by the society and also by wrong information and advice on 
websites or magazines. 
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8.0 Prospective: 
We believe that future risk management studies should work on and consider all target 
suggestions given in the discussion in order to counteract the wide spreading of AAS among 
laypeople that have all possible different motivations for using AAS. 
Indeed, future studies will also need to point out the profile of the average AAS user, that is, 
the exact position of the majority of AAS users in between the “two extreme profiles”. 
Moreover, if our hypothesis of big differences in AAS consumers‟ profiles in different people 
will be confirmed, there will also be the need to map the differences among countries, social 
class, educational background, gender and age of the users. In this way, management risk 
campaigns will be able to focus their efforts against AAS usage by targeting the reasons that 
bring the majority of AAS users to consume AAS. 
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10.0 Appendix 
Definition of the following terms have been quoted from Oxford Dictionary of Biochemistry 
and Molecular Biology, Revised Edition 2004. 
 
ADENOHYPOPHYSIS: the glandular anterior lobe of the hypophysis (or pituary gland) 
ADRENAL CORTEX: see adrenal gland 
ADRENAL GLAND: an endocrine organ in vertebrates. There is a single pair in mammals, 
one near each kidney. The gland has two components: an inner medulla, derived from the 
neural crest, that biosynthesizes and secretes epinephrine and norepinephrine; and an outer 
cortex, derived from the coelom, that is concerned in the biosynthesis and secretion of steroid 
hormones. The cortex consists in turn of three histologically defined zones: an outer zone 
glomerulosa, the cells of which are responsible for the biosynthesis aldosterone and 
deoxycorticosterone; an intermediate zona fasciculata; and an inner zona reticularis. The cells 
of the zona fasciculata and zona reticularis are responsable for the biosynthesis of the 
glucocorticoid cortisol and the androgens dehydroepiandrosterone and androstenedione. 
cAMP: adenosine 3',5'-phosphate (cyclic adenosine 3',5'-monophosphate): a 
mopnophosphoric diester of adenosine. It is a universally distribuited key metabolite, 
produced by the action of adenylate cyclase on adenosine 5'-triphosphate, ATP. The fist 
compound to be named second messenger, it mediates many effects in signal transduction 
pathways. It was first identified as a heat-stable activator of glycogen phosphorylase kinase, 
and is now known also to activate cyclic-AMP-dependent protein kinase and to regulate 
numerous other enzymatic activities or physiological processes. 
CHAPERONE: any of a functional class of unrelated families of proteins that assist the 
correct non-covalent assembly of other polypeptide-containing structures in vivo, but are not 
components of these assembled structures when they are performing their normal biological 
functions. 
CORTICOTROPIN: a 39-residue polypeptide hormone, secreted by the adenohypophysis of 
the pituitary, that stimulated growth of the adrenal cortex and the synthesis and secretion of 
various corticosteroids. 
EPO: Erythropoietin: a 46 kDa mammalian glycoprotein cytokine, formed in the kidneys and 
liver of mammalians, that stimulates cellular differentiation of bone-marrow stem cells at an 
early stage of erythropoiesis, accelerates the proliferation and maturation of terminally 
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differentiating cells into erythrocytes, and maintains a physiological level of circulating 
erythrocyte mass. 
GABA: ɤ-Aminobutyric acid: an amino acid not found in proteins but occurring principally in 
the central nervous system, where it is an important inhibitory neurotransmitter. 
GABA receptor: any of several membrane proteins that bind gamma-aminobutyrate (GABA) 
and mediate its effects as an inhibitory neurotransmitter. Two main types have been 
distinguished: GABAa receptors, known also as GABA-gated channels, which function as a 
Cl
-
 channel; GABAb receptors, which are G-protein-coupled receptors. 
GnRH: Gonadotropin-releasing hormone: a family of decapeptide amides, of which there are 
at least seven members. It is name after its function in mammals, in which it is released by the 
hypothalamus into the hypophyseal portal circulation in response to neural and/or chemical 
stimuli. 
GLUCOCORTICOID: any naturally occurring or synthetic hormonal corticosteroid that acts 
primarily on carbohydrate and protein metabolism, e.g. by promoting hepatic glycogen 
deposition, and that has an anti-inflammatory effect. Glucocorticoids are produced in the 
middle layer of the adrenal cortex, and include cortisol, corticosterone and cortisone. 
Glucocorticoid secretion is enhanced during stress, including hypoglucemia, hypotension, 
trauma and illness. The main physiological actions of glucocorticoids include stimulation of 
liver glucose output, inhibition of glucose utilization by tissues, mobilization of amino acids 
by breakdown of muscle proteins, and mobilization of fatty acids from adipose tissue. 
GLUCOCORTICOID RECEPTOR: a mammalian transcription factor involved in the 
regulation of eukaryotic gene expression and affecting cellular proliferation and 
differentiation in target tissues. 
HDL: High-density lipoprotein: one of the classes of lipoproteins found in blood plasma in 
many animals. HDL particles are the smallest of the blood lipoproteins. They are synthesized 
in liver as precursor molecules, which undergo modification in plasma to the mature 
molecules, especially as a result of the action of lecithin-cholesterol acyltransferase. They 
appear to function in reverse transport of cholesterol from tissue to liver. 
HEAT SHOCK PROTEIN (Hsp): any of a group of specific proteins that are synthesized by 
both prokaryotic and eukaryotic cells after they have been exposed to a temperature that is 
higher than normal. Other stresses, such as free-radical damage, have a similar effect. Many 
members of the Hsp family are not induced but are normally present in all cells. The heat 
shock proteins are classified, according to their size, in three classes, Hsp60, Hsp70, Hsp90. 
They are characterized by their role as molecular chaperones. 
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INSULIN-LIKE GROWTH FACTOR: any member of a group of polypeptides that are 
structurally homologous to insulin and share many of its biological activities but are 
immunologically distinct from it; they are mitogens of the insulin/relaxin family. They include 
substances now named insulin-like growth factor-I (IGF-I) which is a monomer of 70 amino 
acids, and insulin-like growth factor-II (IGF-II) which is a monomer of 67 amino acids. 
LDL: Low-density lipoprotein: one of the classes of lipoproteins found in blood plasma in 
many animals. They are synthesized in plasma from very low density lipoproteins and 
intermediate density lipoproteins through the action of lipoprotein lipase; they transport 
cholesterol to peripheral tissues. They have the highest content of cholesterol of any plasma 
lipoprotein, and have been linked to the incidence of coronary heart disease in 
epidemiological studies.  
PKC: Protein kinase C: any of a family of protein kinase enzymes identified following 
discovery of a protein kinase requiring anionic phospholipid for activity, and regulated by 
diacylglucerol and Ca
2+
.They phosphorylate hydroxyl groups in substrate serine and threonine 
residues. 
